Drug-Resistant Fungus Spreads in Dhaka ICUs
Analysis based on 8 articles · First reported Mar 03, 2026 · Last updated Mar 03, 2026
The spread of drug-resistant Candida auris in Bangladesh===Dhaka's ICUs poses a negative impact on the healthcare sector, potentially increasing treatment costs and patient mortality. This event could lead to increased demand for new antifungal drugs and improved infection control technologies, affecting pharmaceutical and biotechnology companies.
A study conducted by icddr,b revealed that Candida auris, a hard-to-treat drug-resistant fungus, is spreading in intensive care units in Bangladesh===Dhaka, Bangladesh. The 'superbug' is affecting critically ill patients beyond neonatal units, raising concerns about hospital-acquired infections. The study, a collaboration with IEDCR and technical support from CDC, found that approximately 7% of patients carried C. auris, with over one-third acquiring it within the ICU. Public hospitals showed higher transmission rates (13%) compared to private hospitals (4%). All C. auris samples were resistant to fluconazole, and nearly all to voriconazole, highlighting the challenge in treatment. Genetic analysis confirmed the strains belong to a South Asian lineage, indicating the fungus is established in the region. Researchers recommend rigorous cleaning, strict hand hygiene, and routine screening to combat the spread.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard